Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.660
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
2.690
+0.030 (1.13%)
After-hours: May 22, 2026, 7:55 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $342.27 million as of May 22, 2026. Its market cap has decreased by -49.47% in one year.
Market Cap
342.27M
Enterprise Value
321.76M
1-Year Change
-49.47%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $342.27M, a decrease of -72.32%. That is a compound annual growth rate of -15.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 342.27M | -47.94% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tilray Brands | 631.01M |
| Aquestive Therapeutics | 516.85M |
| Kamada | 455.37M |
| Emergent BioSolutions | 435.99M |
| Canopy Growth | 411.58M |
| Evolus | 401.06M |
| SIGA Technologies | 335.67M |
| Akebia Therapeutics | 273.62M |